A - Human Necessities – 61 – B
Patent
A - Human Necessities
61
B
A61B 10/00 (2006.01) A61B 10/02 (2006.01) G01N 33/48 (2006.01)
Patent
CA 2690520
Disclosed is a method and apparatus for accomplishing a noninvasive screen for breast disease markers, including breast cancer markers and cytologically abnormal cells. Intraductal fluid is noninvasively aspirated using compression, heating, and suction cycles. The removed sample is thereafter assayed for the presence of cytologically abnormal cells and/or one or more breast disease markers. Sample size and intraductal mobility of breast disease markers may be enhanced by retrograde introduction of a carrier. A portable, self-contained intraductal fluid aspiration device (20) includes a housing (22), one or more controls and/or indicators (25), and a patient or breast interface (24) having a tissue contacting surface (32) for receiving a breast and a second concavity (38) for receiving a nipple. Preferably, the breast interface (24) is provided with a dynamic compression zone (42), having one or more compression elements (45) for compression in the mid breast region to facilitate intraductal fluid aspiration.
Mbm Intellectual Property Law Llp
Neomatrix Inc.
Neomatrix Llc
LandOfFree
Noninvasive intraductal fluid diagnostic screen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Noninvasive intraductal fluid diagnostic screen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Noninvasive intraductal fluid diagnostic screen will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1816706